• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阳性和阴性症状量表的项目反应分析

Item response analysis of the Positive and Negative Syndrome Scale.

作者信息

Santor Darcy A, Ascher-Svanum Haya, Lindenmayer Jean-Pierre, Obenchain Robert L

机构信息

School of Psychology, University of Ottawa, Ottawa, Canada, and The Provincial Centre of Excellence for Child and Youth Mental Health, Ottawa, Ontario, Canada.

出版信息

BMC Psychiatry. 2007 Nov 15;7:66. doi: 10.1186/1471-244X-7-66.

DOI:10.1186/1471-244X-7-66
PMID:18005449
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2211479/
Abstract

BACKGROUND

Statistical models based on item response theory were used to examine (a) the performance of individual Positive and Negative Syndrome Scale (PANSS) items and their options, (b) the effectiveness of various subscales to discriminate among individual differences in symptom severity, and (c) the appropriateness of cutoff scores recently recommended by Andreasen and her colleagues (2005) to establish symptom remission.

METHODS

Option characteristic curves were estimated using a nonparametric item response model to examine the probability of endorsing each of 7 options within each of 30 PANSS items as a function of standardized, overall symptom severity. Our data were baseline PANSS scores from 9205 patients with schizophrenia or schizoaffective disorder who were enrolled between 1995 and 2003 in either a large, naturalistic, observational study or else in 1 of 12 randomized, double-blind, clinical trials comparing olanzapine to other antipsychotic drugs.

RESULTS

Our analyses show that the majority of items forming the Positive and Negative subscales of the PANSS perform very well. We also identified key areas for improvement or revision in items and options within the General Psychopathology subscale. The Positive and Negative subscale scores are not only more discriminating of individual differences in symptom severity than the General Psychopathology subscale score, but are also more efficient on average than the 30-item total score. Of the 8 items recently recommended to establish symptom remission, 1 performed markedly different from the 7 others and should either be deleted or rescored requiring that patients achieve a lower score of 2 (rather than 3) to signal remission.

CONCLUSION

This first item response analysis of the PANSS supports its sound psychometric properties; most PANSS items were either very good or good at assessing overall severity of illness. These analyses did identify some items which might be further improved for measuring individual severity differences or for defining remission thresholds. Findings also suggest that the Positive and Negative subscales are more sensitive to change than the PANSS total score and, thus, may constitute a "mini PANSS" that may be more reliable, require shorter administration and training time, and possibly reduce sample sizes needed for future research.

摘要

背景

基于项目反应理论的统计模型用于检验:(a) 阳性和阴性症状量表(PANSS)各项目及其选项的性能;(b) 各种分量表在区分症状严重程度个体差异方面的有效性;(c) 安德烈亚森及其同事(2005年)最近推荐的用于确定症状缓解的临界分数的适宜性。

方法

使用非参数项目反应模型估计选项特征曲线,以检验30个PANSS项目中每个项目的7个选项中每个选项被认可的概率,该概率是标准化总体症状严重程度的函数。我们的数据是1995年至2003年期间纳入一项大型自然观察性研究或12项将奥氮平与其他抗精神病药物进行比较的随机双盲临床试验之一的9205例精神分裂症或分裂情感性障碍患者的PANSS基线评分。

结果

我们的分析表明,构成PANSS阳性和阴性分量表的大多数项目表现良好。我们还确定了一般精神病理学分量表中项目和选项需要改进或修订的关键领域。阳性和阴性分量表分数不仅比一般精神病理学分量表分数更能区分症状严重程度的个体差异,而且平均而言比30项总分更有效。在最近推荐用于确定症状缓解的8个项目中,有1个项目与其他7个项目的表现明显不同,要么应删除,要么重新计分,要求患者达到更低的2分(而非3分)以表明缓解。

结论

对PANSS的首次项目反应分析支持其良好的心理测量特性;大多数PANSS项目在评估疾病总体严重程度方面要么非常好,要么良好。这些分析确实识别出了一些项目,这些项目在测量个体严重程度差异或定义缓解阈值方面可能需要进一步改进。研究结果还表明,阳性和阴性分量表比PANSS总分对变化更敏感,因此可能构成一个“迷你PANSS”,可能更可靠,需要更短的施测和培训时间,并可能减少未来研究所需的样本量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c2c/2211479/4c36c9c9017f/1471-244X-7-66-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c2c/2211479/41195e45bd73/1471-244X-7-66-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c2c/2211479/dd297e795c80/1471-244X-7-66-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c2c/2211479/0728be451197/1471-244X-7-66-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c2c/2211479/ac3123b0771f/1471-244X-7-66-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c2c/2211479/89a173491e51/1471-244X-7-66-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c2c/2211479/39a8afa89456/1471-244X-7-66-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c2c/2211479/4c36c9c9017f/1471-244X-7-66-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c2c/2211479/41195e45bd73/1471-244X-7-66-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c2c/2211479/dd297e795c80/1471-244X-7-66-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c2c/2211479/0728be451197/1471-244X-7-66-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c2c/2211479/ac3123b0771f/1471-244X-7-66-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c2c/2211479/89a173491e51/1471-244X-7-66-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c2c/2211479/39a8afa89456/1471-244X-7-66-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c2c/2211479/4c36c9c9017f/1471-244X-7-66-7.jpg

相似文献

1
Item response analysis of the Positive and Negative Syndrome Scale.阳性和阴性症状量表的项目反应分析
BMC Psychiatry. 2007 Nov 15;7:66. doi: 10.1186/1471-244X-7-66.
2
Use of non-parametric item response theory to develop a shortened version of the Positive and Negative Syndrome Scale (PANSS).运用非参数项目反应理论开发简明版阳性与阴性症状量表(PANSS)。
BMC Psychiatry. 2011 Nov 16;11:178. doi: 10.1186/1471-244X-11-178.
3
[A four-dimensional model of chronic schizophrenia based on the factorial structure of the Positive and Negative Syndrome Scale (PANSS). A study of a group of 153 chronic schizophrenic patients and comparison with the factorial structure of the BPRS].基于阳性和阴性症状量表(PANSS)因子结构的慢性精神分裂症四维模型。对153例慢性精神分裂症患者的研究及与简明精神病评定量表(BPRS)因子结构的比较
Encephale. 1997 Jan-Feb;23(1):10-8.
4
Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study.在典型或非典型抗精神病药物治疗失败后,奥氮平用于难治性精神分裂症:一项开放标签转换研究。
J Clin Psychiatry. 2002 Oct;63(10):931-5. doi: 10.4088/jcp.v63n1011.
5
[Influence of resistance to voices on depression].[对幻听的抵抗对抑郁症的影响]
Encephale. 2015 Feb;41(1):25-31. doi: 10.1016/j.encep.2014.01.006. Epub 2014 May 9.
6
The multidimensional measurement of the positive symptoms of psychosis.精神病阳性症状的多维测量。
Int J Methods Psychiatr Res. 2007;16(2):88-96. doi: 10.1002/mpr.203.
7
The heterogeneity of antipsychotic response in the treatment of schizophrenia.抗精神病药治疗精神分裂症反应的异质性。
Psychol Med. 2011 Jun;41(6):1291-300. doi: 10.1017/S0033291710001893. Epub 2010 Oct 7.
8
Comparison of risperidone and olanzapine in the control of negative symptoms of chronic schizophrenia and related psychotic disorders in patients aged 50 to 65 years.利培酮与奥氮平对50至65岁慢性精神分裂症及相关精神障碍患者阴性症状控制效果的比较
J Clin Psychiatry. 2003 Sep;64(9):998-1004. doi: 10.4088/jcp.v64n0904.
9
Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.非典型抗精神病药物治疗精神分裂症和分裂情感性障碍的暴力患者。
Arch Gen Psychiatry. 2006 Jun;63(6):622-9. doi: 10.1001/archpsyc.63.6.622.
10
Efficacy and tolerability of ziprasidone versus risperidone in patients with acute exacerbation of schizophrenia or schizoaffective disorder: an 8-week, double-blind, multicenter trial.齐拉西酮与利培酮治疗精神分裂症或分裂情感性障碍急性加重患者的疗效与耐受性:一项为期8周的双盲多中心试验。
J Clin Psychiatry. 2004 Dec;65(12):1624-33. doi: 10.4088/jcp.v65n1207.

引用本文的文献

1
Replicating and Extending the Reliability, Criterion Validity, and Treatment Sensitivity of the PANSS10 and PANSS20 for Pediatric Trials.复制并扩展阳性和阴性症状量表10项版(PANSS10)及阳性和阴性症状量表20项版(PANSS20)在儿科试验中的信度、效标效度及治疗敏感性。
JAACAP Open. 2024 May 23;3(2):257-267. doi: 10.1016/j.jaacop.2024.02.010. eCollection 2025 Jun.
2
COSMIN systematic review and meta-analysis of the measurement properties of the Positive and Negative Syndrome Scale (PANSS).COSMIN对阳性和阴性症状量表(PANSS)测量属性的系统评价与Meta分析。
EClinicalMedicine. 2025 Apr 11;82:103155. doi: 10.1016/j.eclinm.2025.103155. eCollection 2025 Apr.
3

本文引用的文献

1
Factor structure and external validity of the PANSS revisited.再探阳性和阴性症状量表(PANSS)的因子结构与外部效度
Schizophr Res. 2006 Feb 28;82(2-3):213-23. doi: 10.1016/j.schres.2005.09.002. Epub 2005 Oct 17.
2
Remission in schizophrenia: proposed criteria and rationale for consensus.精神分裂症的缓解:共识的提议标准及基本原理
Am J Psychiatry. 2005 Mar;162(3):441-9. doi: 10.1176/appi.ajp.162.3.441.
3
The effects of olanzapine on the 5 dimensions of schizophrenia derived by factor analysis: combined results of the North American and international trials.
Longitudinal analysis of proinflammatory and anti-inflammatory cytokines in the cerebrospinal fluid and peripheral blood of treatment-naïve first-episode psychosis patients, and their correlation with psychosis severity and cognitive impairment in sub-Saharan Africa.
对撒哈拉以南非洲地区初发未治疗的首发精神病患者脑脊液和外周血中促炎和抗炎细胞因子的纵向分析,及其与精神病严重程度和认知障碍的相关性。
BMJ Open. 2025 Apr 2;15(4):e098347. doi: 10.1136/bmjopen-2024-098347.
4
COSMIN review of the PANSS Marder factor solution and other factor models in people with schizophrenia.精神分裂症患者中阳性和阴性症状量表(PANSS)的马德因子解及其他因子模型的COSMIN综述。
Schizophrenia (Heidelb). 2025 Mar 31;11(1):51. doi: 10.1038/s41537-025-00600-6.
5
Replicating and extending the reliability, criterion validity, and treatment sensitivity of the shortened PANSS for pediatric trials.复制并扩展缩短版阳性和阴性症状量表在儿科试验中的信度、效标效度及治疗敏感性。
Eur Child Adolesc Psychiatry. 2025 Mar 10. doi: 10.1007/s00787-025-02681-1.
6
Rare Case of Acute Psychotic Disorder Associated with Immunosuppressant Medications Use After Kidney Transplantation.肾移植后使用免疫抑制剂药物引发急性精神病性障碍的罕见病例。
Psychiatry Clin Psychopharmacol. 2024 Nov 29;34(4):361-364. doi: 10.5152/pcp.2024.24914.
7
Extension and Further Replication of the Reliability, Criterion Validity, and Treatment Sensitivity of the PANSS10 and PANSS20 for Pediatric Trials.PANSS10和PANSS20在儿科试验中的信度、效标效度及治疗敏感性的扩展与进一步验证
J Child Adolesc Psychopharmacol. 2024 Dec;34(10):447-457. doi: 10.1089/cap.2024.0078. Epub 2024 Oct 17.
8
Validation of Chinese Version of Positive and Negative Syndrome Scale-6 in Clinical Setting: A Preliminary Study.阳性与阴性症状量表-6中文版在临床环境中的效度验证:一项初步研究
Psychiatry Clin Psychopharmacol. 2021 Dec 1;31(4):386-391. doi: 10.5152/pcp.2021.21060. eCollection 2021 Dec.
9
Fibre density and fibre-bundle cross-section of the corticospinal tract are distinctly linked to psychosis-specific symptoms in antipsychotic-naïve patients with first-episode schizophrenia.皮质脊髓束的纤维密度和纤维束横截面积与首发精神分裂症抗精神病药物初治患者的精神病特异性症状明显相关。
Eur Arch Psychiatry Clin Neurosci. 2023 Dec;273(8):1797-1812. doi: 10.1007/s00406-023-01598-7. Epub 2023 Apr 4.
10
Shortened Positive and Negative Symptom Scale as an Alternate Clinical Endpoint for Acute Schizophrenia Trials: Analysis from the US Food & Drug Administration.简明阳性和阴性症状量表作为急性精神分裂症试验的替代临床终点:来自美国食品药品监督管理局的分析
Psychiatr Res Clin Pract. 2020 Nov 6;3(1):38-45. doi: 10.1176/appi.prcp.20200003. eCollection 2021 Spring.
奥氮平对通过因子分析得出的精神分裂症五个维度的影响:北美和国际试验的综合结果
J Clin Psychiatry. 2001 Oct;62(10):757-71. doi: 10.4088/jcp.v62n1003.
4
Examining symptom expression as a function of symptom severity: item performance on the Hamilton Rating Scale for Depression.将症状表现作为症状严重程度的函数进行考察:抑郁症状汉密尔顿评定量表的项目表现
Psychol Assess. 2001 Mar;13(1):127-39.
5
Five-factor model of schizophrenic psychopathology: how valid is it?精神分裂症精神病理学的五因素模型:其有效性如何?
Eur Arch Psychiatry Clin Neurosci. 2000;250(2):93-100. doi: 10.1007/s004060070041.
6
Internal consistency, temporal stability and neuropsychological correlates of three cognitive components of the Positive and Negative Syndrome Scale (PANSS).阳性和阴性症状量表(PANSS)三个认知成分的内部一致性、时间稳定性及神经心理学相关性
Schizophr Res. 1999 Jul 27;38(1):27-35. doi: 10.1016/s0920-9964(99)00004-3.
7
Factorial structure of the Positive and Negative Syndrome Scale (PANSS): a forced five-dimensional factor analysis.阳性和阴性症状量表(PANSS)的因子结构:强制五维因子分析
Acta Psychiatr Scand. 1998 Nov;98(5):369-76. doi: 10.1111/j.1600-0447.1998.tb10101.x.
8
The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials.利培酮对通过因子分析得出的精神分裂症五个维度的影响:北美试验的综合结果。
J Clin Psychiatry. 1997 Dec;58(12):538-46. doi: 10.4088/jcp.v58n1205.
9
Empirical assessment of the factorial structure of clinical symptoms in schizophrenia. A multisite, multimodel evaluation of the factorial structure of the Positive and Negative Syndrome Scale. The PANSS Study Group.精神分裂症临床症状因子结构的实证评估。阳性与阴性症状量表因子结构的多中心、多模型评估。阳性与阴性症状量表研究组
Psychopathology. 1997;30(5):263-74. doi: 10.1159/000285058.
10
Psychometric properties of the positive and negative syndrome scale (PANSS) in schizophrenia.精神分裂症中阳性和阴性症状量表(PANSS)的心理测量特性。
Psychiatry Res. 1994 Jul;53(1):31-40. doi: 10.1016/0165-1781(94)90093-0.